Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramipexole ER versus pramipexole IR and placebo in early Parkinson's disease
2007-000073-39Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of pramipexole in Parkinson's disease (PD) (3 arms), sponsored by Boehringer Ingelheim. Started Feb 2007; status: completed.
02
Drugs
pramipexole
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2007-000073-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000073-39.